POLYOMAVIRUS DISEASE UNDER NEW IMMUNOSUPPRESSIVE DRUGS

1999446 citationsJournal Article

Authors

Isabelle Binet

Volker Nickeleit · Taipei Institute of Pathology

Hans H. Hirsch

Olivier D. Prince · Taipei Institute of Pathology

Peter Dalquen · Taipei Institute of Pathology

F Gudat · Taipei Institute of Pathology

Michael J. Mihatsch · Taipei Institute of Pathology

G Thiel

Abstract

Recurrent rejection episodes and high dose immunosuppressive therapy, including tacrolimus, are risk factors for manifest PV kidney graft infection, which has an ominous prognosis.

Topics & Keywords

Polyomavirus and related diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplantation

Volume 67, Issue 6, pp. 918-922

DOI: 10.1097/00007890-199903270-00022

Field-Weighted Citation Impact: 7.00